Results 171 to 180 of about 24,501 (255)

The Glymphatic System in Traumatic Brain Injury, Subarachnoid Hemorrhage, and Neurodegeneration: A Unifying Neurobiological Framework. [PDF]

Biomedicines
Haq NU, Irshad SU, Bibi Z, Rehman S, Sohail S, Irshad SR, Haider NU, Mir S, Shareef A, Lucke-Wold B.   +9 more
europepmc   +1 more source

Proportion and Clinical Characteristics of Double‐Seronegative NMOSD in a Multicenter Real‐World Cohort

European Journal of Neurology, Volume 33, Issue 11, November 2026.
ABSTRACT Background Recent 2025 neuromyelitis optica spectrum disorder (NMOSD) criteria distinguish AQP4‐IgG‐positive disease from seronegative‐syndromic groups, into which double‐seronegative‐NMOSD (DN‐NMOSD) may be reclassified, suggesting the need to better characterize DN‐NMOSD within prior diagnostic frameworks.
Jae‐Won Hyun, Ki Hoon Kim, Seung Woo Kim, Ha Young Shin, You‐Ri Kang, Tai‐Seung Nam, Woojun Kim, Su‐Hyun Kim, Ho Jin Kim   +8 more
wiley   +1 more source

Noncoding RNAs as novel diagnostic biomarkers for diabetic retinopathy: A systematic review and meta‐analysis

Journal of Diabetes Investigation, Volume 17, Issue 11, Page 1967-1977, November 2026.
The systematic review and meta‐analysis (Embase, PubMed, and Web of Science; up to August 2025) evaluated circulating noncoding RNAs (ncRNAs) as noninvasive early diagnostic biomarkers for diabetic retinopathy (DR). From 17 articles (24 studies, 1,983 DR patients vs 1,437 controls), a random‐effects model yielded pooled sensitivity of 0.81, specificity
Ting Zhang, Donghong Xu
wiley   +1 more source

Anti-AQP4-Antikörper [PDF]

, 2019
openaire   +1 more source

Serum GFAP and Age Accurately Distinguish AQP4-IgG Positive and Double Seronegative NMOSD From MOGAD After a Recent Attack. [PDF]

Eur J Neurol
Rival M, Rollot F, Laurent-Chabalier S, Casey R, El Bahi I, Brocard G, Marignier R, Trouillet-Assant S, Vukusic S, Fromont A, Laplaud DA, Mathey G, Maillart E, Michel L, Ruet A, Labauge P, Ayrignac X, Zephir H, Ciron J, de Sèze J, Kwiatkowski A, Papeix C, Branger P, Lebrun-Frenay C, Berger E, Clavelou P, Heinzlef O, Pelletier J, Al-Khedr A, Casez O, Bourre B, Créange A, David T, Magy L, Camdessanche JP, Doghri I, Dos Santos A, Mura T, Agherbi H, Thouvenot E, OFSEP Group and NOMADMUS Investigators.   +40 more
europepmc   +1 more source

Application of Optic Neuritis Diagnostic Criteria in Autoimmune Paraneoplastic CRMP5 Optic Neuropathy and Development of the "CRMP" Score. [PDF]

Neurol Neuroimmunol Neuroinflamm
Dinoto A, Cohen DA, Cacciaguerra L, Tisavipat N, Syc-Mazurek SB, Lennon VA, Bhatti MT, Tajfirouz DA, Chodnicki KD, Pittock SJ, Flanagan EP, Chen JJ.   +11 more
europepmc   +1 more source

Aquaporin water channels: distribution, physiology, pathophysiology, and relevance as therapeutic targets. [PDF]

Mol Biomed
Wang L, Luo Y, Deng X, Chen J, Wang L, Wu T.   +5 more
europepmc   +1 more source

Glymphatic Dysfunction Across Neurological Disorders: Links to Neurodegeneration, Inflammaging, Gut-Brain Signaling, and Physiological Modulators. [PDF]

Biomedicines
Voumvourakis KI, Thomaidis NS, Sideri E, Papadimitropoulos GN, Liadinioti C, Tsivgoulis G, Tsiodras S.   +6 more
europepmc   +1 more source

The role of glymphatic system in brain injury after subarachnoid hemorrhage. [PDF]

Front Immunol
Peng J, Li W, Zhong Q, Li L, Tang S, Li Y, Liu Q.   +6 more
europepmc   +1 more source

CO:08:1 | Aquaporin-4 downregulation in dysphagic idiopathic inflammatory myopathies: association with Type 2 fiber damage and inflammation

Reumatismo
Background. To assess whether Aquaporin-4 (AQP4) expression in skeletal muscle is altered in idiopathic inflammatory myopathies (IIMs), particularly in dysphagic patients, and to explore its association with muscle fiber type, regeneration, inflammation,
Società Italiana di Reumatologia
doaj